← Evidence map

ReviewCNS drugs2011

Antipsychotic polypharmacy in schizophrenia: benefits and risks.

Thomas R E Barnes et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

64 papers cite itlatest 60 shown

2011
…
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2026
this paperpooled ittrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 21476610